Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
HSIC 
Henry Schein Inc (HSIC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/24/2025: HSIC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
16 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $77.64
1 Year Target Price $77.64
| 3 | Strong Buy |
| 4 | Buy |
| 8 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -19.46% | Avg. Invested days 38 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/24/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.24B USD | Price to earnings Ratio 24.03 | 1Y Target Price 77.64 |
Price to earnings Ratio 24.03 | 1Y Target Price 77.64 | ||
Volume (30-day avg) 16 | Beta 0.89 | 52 Weeks Range 60.56 - 82.49 | Updated Date 12/25/2025 |
52 Weeks Range 60.56 - 82.49 | Updated Date 12/25/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3.17 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.02% | Operating Margin (TTM) 6.14% |
Management Effectiveness
Return on Assets (TTM) 4.23% | Return on Equity (TTM) 8.35% |
Valuation
Trailing PE 24.03 | Forward PE 14.53 | Enterprise Value 12274453045 | Price to Sales(TTM) 0.71 |
Enterprise Value 12274453045 | Price to Sales(TTM) 0.71 | ||
Enterprise Value to Revenue 0.95 | Enterprise Value to EBITDA 12.95 | Shares Outstanding 117724807 | Shares Floating 98184844 |
Shares Outstanding 117724807 | Shares Floating 98184844 | ||
Percent Insiders 0.89 | Percent Institutions 110.67 |
Upturn AI SWOT
Henry Schein Inc
Company Overview
History and Background
Founded in 1932 by Henry Schein, Henry Schein, Inc. (HSIC) has grown from a small New York City dental supply distributor into a global leader in healthcare solutions. Significant milestones include its initial public offering in 1995, consistent expansion into new product lines and geographic markets, and the establishment of its Animal Health and Medical distribution businesses. The company has evolved by adapting to changing healthcare needs and leveraging technology to serve dental, medical, and veterinary professionals.
Core Business Areas
- Dental: Distributes a comprehensive range of dental products, including equipment, instruments, consumables, and technology solutions, to dentists and dental laboratories worldwide. This segment also includes practice management software and services.
- Medical: Provides a broad array of medical products and services to physicians, clinics, and hospitals, encompassing pharmaceuticals, medical supplies, diagnostic equipment, and practice management solutions.
- Animal Health: Offers a wide range of animal health products and services to veterinarians, including pharmaceuticals, vaccines, diagnostics, and equipment. This segment also includes practice management software and educational resources.
Leadership and Structure
Henry Schein Inc. is led by a seasoned executive team. Stanley M. Bergman serves as Chairman and Chief Executive Officer. The company operates through its Dental, Medical, and Animal Health segments, with dedicated leadership for each.
Top Products and Market Share
Key Offerings
- Description: A broad category of disposable and regularly replenished items used in dental procedures. Henry Schein holds a significant market share in this segment due to its extensive distribution network and diverse product portfolio. Key competitors include Patterson Dental, Dentsply Sirona, and smaller regional distributors.
- Product Name 1: Dental Consumables (e.g., gloves, masks, impression materials)
- Description: Major capital investments for dental practices. Henry Schein offers a wide range of brands and models, supported by installation and service. Competitors include Patterson Dental, Planmeca, and KaVo Kerr.
- Product Name 2: Dental Equipment (e.g., chairs, X-ray machines)
- Description: Software solutions that help dental and medical practices manage patient records, appointments, billing, and other administrative tasks. Henry Schein's offerings include solutions like Dentrix and EagleSoft. Key competitors include Patterson Dental's Dentrix Enterprise, Carestream Dental, and numerous independent software providers.
- Product Name 3: Practice Management Software
- Description: Essential medications and preventative treatments for animals. Henry Schein's Animal Health segment is a major supplier to veterinary clinics. Competitors include Covetrus, Patterson Veterinary, and manufacturer-direct sales.
- Product Name 4: Veterinary Pharmaceuticals and Vaccines
Market Dynamics
Industry Overview
The healthcare distribution industry, particularly in dental, medical, and animal health, is characterized by fragmentation, consolidation, and a growing demand for integrated solutions. Factors like an aging population, increasing healthcare access, and technological advancements drive market growth. The industry is highly competitive, with a focus on supply chain efficiency, product breadth, and value-added services.
Positioning
Henry Schein is a leading global distributor of healthcare products and services. Its competitive advantages include a vast distribution network, a broad and deep product portfolio, strong customer relationships, and a significant presence in the dental and animal health markets. The company's integrated approach, offering both products and technology solutions, also differentiates it.
Total Addressable Market (TAM)
The total addressable market for dental, medical, and animal health products and services is substantial, estimated to be in the hundreds of billions of dollars globally. Henry Schein is well-positioned to capture a significant portion of this TAM through its established infrastructure, diverse offerings, and ongoing strategic initiatives. The company aims to be the 'partner of choice' for healthcare providers, expanding its reach and service offerings to capture a larger share of customer spending.
Upturn SWOT Analysis
Strengths
- Extensive global distribution network and logistics capabilities.
- Broad and deep product portfolio across dental, medical, and animal health sectors.
- Strong brand recognition and long-standing customer relationships.
- Integrated approach offering products, technology, and services.
- Economies of scale leading to competitive pricing and purchasing power.
Weaknesses
- Reliance on third-party manufacturers for many products.
- Potential for disruption from direct-to-consumer or direct-to-provider sales models.
- Complex organizational structure due to acquisitions and segment diversification.
- Vulnerability to economic downturns affecting healthcare spending.
Opportunities
- Growth in emerging markets and expanding healthcare access.
- Increasing demand for integrated technology solutions (e.g., practice management software, digital dentistry).
- Expansion of value-added services, including consulting and data analytics.
- Strategic acquisitions to enhance product lines or market presence.
- Growing pet ownership driving demand in the animal health sector.
Threats
- Intensifying competition from both large distributors and smaller specialized players.
- Regulatory changes impacting healthcare product sales and distribution.
- Supply chain disruptions and rising raw material costs.
- Cybersecurity threats to sensitive patient and business data.
- Shifts in healthcare delivery models and payer reimbursement policies.
Competitors and Market Share
Key Competitors
- Patterson Companies Inc. (PDCO)
- Cardinal Health Inc. (CAH)
- McKesson Corporation (MCK)
- AmerisourceBergen Corporation (ABC) - Now Cencora
Competitive Landscape
Henry Schein's advantage lies in its specialized focus on dental and animal health, where it holds a leading position. While facing competition from larger, more diversified healthcare distributors like Cardinal Health and McKesson, Henry Schein differentiates itself through its deep understanding of its target markets and its comprehensive suite of solutions beyond just product distribution. Patterson Companies is its most direct competitor, particularly in the dental segment.
Major Acquisitions
Carestream Dental's business assets related to imaging equipment, CAD/CAM, and practice management software in North America and Europe
- Year: 2022
- Acquisition Price (USD millions):
- Strategic Rationale: To bolster its digital dentistry offerings and expand its technology solutions portfolio, enhancing its competitive position in the dental market.
ezyCollect
- Year: 2021
- Acquisition Price (USD millions):
- Strategic Rationale: To enhance its financial solutions for dental practices, particularly in streamlining payment collection and improving cash flow.
Growth Trajectory and Initiatives
Historical Growth: Henry Schein has demonstrated consistent historical growth, fueled by a combination of organic sales increases within its core segments and a robust acquisition strategy. The company has successfully expanded its geographic footprint and product offerings over the decades.
Future Projections: Analyst estimates generally project modest to moderate revenue growth for Henry Schein in the coming years, driven by continued demand in its core markets and potential contributions from new service offerings and digital solutions. Growth is expected to be supported by an aging global population and increasing healthcare expenditure.
Recent Initiatives: Recent strategic initiatives include the expansion of digital platforms, investments in artificial intelligence and data analytics for practice management, and continued focus on supply chain optimization. The company is also actively pursuing synergistic acquisitions to strengthen its market position and expand its service capabilities.
Summary
Henry Schein Inc. is a strong, diversified healthcare distributor with leading positions in dental and animal health. Its extensive network, broad product portfolio, and integrated service offerings are key strengths. While facing competition and market pressures, its focus on technology and value-added services positions it for continued growth. Potential threats include supply chain volatility and evolving healthcare delivery models.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Henry Schein Inc. Investor Relations
- SEC Filings (10-K, 10-Q)
- Financial News Outlets (e.g., Wall Street Journal, Bloomberg)
- Industry Analyst Reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not intended as investment advice. Financial data and market share estimates are subject to change and may vary depending on the source. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Henry Schein Inc
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 1995-11-03 | CEO - | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 25000 | Website https://www.henryschein.com |
Full time employees 25000 | Website https://www.henryschein.com | ||
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.